Clinical Study of Jiangtangbaoshenfang Combined with Irbersartan on Treating Early Diabetic Nephropathy

谢辉,朱琳,黄霖,肖洁,肖云,刘汉欣
DOI: https://doi.org/10.3969/j.issn.1009-587X.2011.07.015
2011-01-01
Abstract:Objective:To investigate the clinical efficacy of Jiangtangbaoshenfang combined with Irbersartan on treating early diabetic nephropathy,it aims to find an optimum way to treat early diabetic nephropathy effectively.Methods:The 108 patients who were in the post-elution period and met the inclusion criteria were randomly divided into the western medicine group(X group),the traditional Chinese medicine group(Z group)and the combining traditional and western medicine group(L group);the patients from X group were given oral irbersartan 150mg per time,once per day;the patients from Z group were given oral Jiangtangbaoshenfang two doses per day;the patients from L group were given oral Jiangtangbaoshenfang two doses per day combined with Irbersartan 150mg per time,once per day,The total treatment time was for 12 weeks.The alteration of symptom,blood glucose,proteinuria,renal function,blood lipids and insulin dosages was observed before and after the treatment.Results:The ALT,ALB,Scr and BUN did not have significant difference among three groups.However,Jiangtangbaoshenfang significantly increased symptom score and significantly decreased TC,TG,HbA1c,insulin dosage,2-hour postprandial blood glucose,24-hour urine protein and 24-hour urinary albumin excretion rate(P<0.05).The combined application of Jiangtangbaoshenfang with Irbersartan had better clinical effect than that of Irbersan and Jiangtangbaoshenfang used respectively(P<0.05).Conclusion:Conclusion:The combination of Jiangtangbaoshenfang with Irbersartan had significant effect on treating early diabetic nephropathy and was worth clinical use.
What problem does this paper attempt to address?